Expired Tender USA ICB TOT Ref. 126546612

Optimizing Treatment Strategies For Adult Tender in USA - 126546612

Tender notice from USA, published on 18 Sep 2025.

Executive Summary

The NATIONAL INSTITUTES OF HEALTH has issued a Tender notice for the procurement of a Optimizing Treatment Strategies For Adult Attention-Deficit Hyperactivity Disorder (Adhd) (R01 Clinical Trial Required) in the USA. This Tender notice was published on 18 Sep 2025 and is scheduled to close on 25 Nov 2025, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 126546612, while the tender notice number is RFA-MH-26-195 and Register on the platform.

Key facts

Summary
Optimizing Treatment Strategies For Adult Attention-Deficit Hyperactivity Disorder (Adhd) (R01 Clinical Trial Required)
TOT Ref. No.
126546612
Document Ref. No.
RFA-MH-26-195
Country
USA
Notice type
Tender
Competition
ICB
Publication date
18 Sep 2025
Bid deadline
25 Nov 2025
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
Public
Financier
Self Financed

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

The Objective Of This Nofo Is To Provide Evidence For The Optimal Treatment Of Adhd In Adults, Given Its Relatively Recent Acceptance As A Formal Diagnostic Category. While Stimulant Drugs Offer The Advantages Of Rapid Onset Of Action And History Of Efficacy, The Risk Of Adverse Effects, Dependence, Misuse, And Diversion, Along With Recent Medication Shortages, Underscore The Importance Of Studying Evidence-Based Complementary And Alternative Approaches When Indicated. Clinical Trials Testing Non-Stimulant Medications, Psychosocial Interventions, And Device-Based Approaches, Sequentially Or In Combination, To Augment Or Replace Stimulants In Situations Where Stimulant Monotherapy Is Insufficiently Effective, Difficult To Tolerate, Or Undesirable, In The Acute And Post-Acute Treatment Of Adhd In Adults, Or In Preventing The Transition Of Adhd Symptoms From Adolescence To Adulthood, Will Be Supported By This Nofo.
Opportunity Category : Discretionary

Opportunity Category Explanation :

Funding Instrument Type : Grant

Category of Funding Activity : Health

CFDA_Number :
Posted Date : Sep 17, 2025

Last Updated Date : Sep 17, 2025

Documents

Tender Notice
Login to view

USA Public Procurement Intelligence

Frequently asked questions

The bid deadline for Optimizing Treatment Strategies For Adult Attention-Deficit Hyperactivity Disorder (Adhd) (R01 Clinical Trial Required) was 25 Nov 2025. Bidding is closed.

This tender has been issued by NATIONAL INSTITUTES OF HEALTH in USA.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 126546612. The purchaser document reference is RFA-MH-26-195.

Browse other tenders from USA or search by relevant keywords and CPV classification.